Work

Correction to: Continous or fixed carfilzomib, lenalidomide and dexamethasone (KRD) for relapsed-refractory multiple myeloma: long-term follow-up from a multicenter, retrospective real-life survey from European myeloma network (EMN) Italy

Year: 2025
Type: erratum
Abstract: myeloma network (EMN) Italy
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: gold
Estimated APC paid: $4,590
OpenAlex ID: W4416155934
Cites:
Cited by:
Related to: